1. Aliski WE, Cashon GW, and Osband ME (1991) The regulation of living cell therapies (Biocare). Regulatory Affairs 3: 639–650.
2. Arnow PM, Houchins SG, Richards JM, and Chudy R (1991) Aspirgillus fumigatus contamination of lymphokine — activated killer cells infused into cancer patients. J. Clin. Microbiol. 29: 1038–1041.
3. du Moulin GC, Hamilton DL, Price JE, Kosik ZJ, Liu VYS, Osband ME (1990) Quality assurance and quality control (QA/QC) in biocare. Autolymphocyte therapy as a model. Biopharm. 3: 30–35.
4. du Moulin GC, Price JE, Shen YJ, and Osband ME (1992) Use of the Limulus amebocyte lysate (LAL) assay in living cell therapies. Biopharm. 5: 32–54.
5. du Moulin GC, Liu V, and Osband ME (1992) Implementation of an effective program for quality assurance and quality control in living cell therapy: A two year experience with autolymphocyte therapy. Transplantation Proceedings 24: 2803–2808.